healthcentral.com
Cure8 news brief
Why This Matters
This matters because regular ileocolonoscopies are invasive, costly, and carry risks. If fecal calprotectin reliably rules out significant recurrence for people in deep remission or with low‑risk findings, some patients may safely need scopes less often.
Who Should Pay Attention
Adult Crohn’s patients in remission or considered low risk after surgery, gastroenterologists and IBD clinicians, and people interested in noninvasive monitoring methods.
Study Snapshot
Story typeResearch news
Evidence typeClinical study
Source depthFull source text
What To Know
A recent clinical study and expert commentary discussed using fecal calprotectin (FC) testing to monitor low‑risk Crohn’s patients after surgery as a way to reduce the frequency of follow-up ileocolonoscopies.
The study followed 55 people considered low risk and collected stool FC every four months; investigators reported that two consecutive FC values below 250 µg/g (and often <100 µg/g) were associated with no endoscopic recurrence during the study window.
Experts quoted in the article note FC testing is noninvasive and cost‑effective but can give false low or high readings in certain situations (patchy small‑bowel disease, NSAIDs, infections, hemorrhoids, etc.), so results must be interpreted with clinical context.
Keep In Mind
Findings come from a single observational study with 55 participants and expert commentary; thresholds and monitoring intervals (e.g., two consecutive FC <250 µg/g) are study‑specific and not yet universal guidelines.
FC can be affected by non‑IBD factors and may miss small‑bowel, patchy inflammation, so clinicians will likely combine FC with symptoms and other tests before changing surveillance schedules.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationhealthcentral.com
Indexed viaGoogle News
Source typeResearch news
PublishedApr 15, 2025, 11:51 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Faecal Calprotectin Predicts Inflammation in Crohn’s Disease
Faecal calprotectin from ileostomy output could provide a non-invasive way to detect small-bowel inflammation after surgery, helping to guide monitoring and reduce reliance on invasive tests for postoperative Crohn’s...
How to reduce the number of colonoscopies and improve follow-up for patients with Crohn's disease
Frequent routine colonoscopies after Crohn's surgery are invasive and burdensome. Using fecal calprotectin for regular monitoring could reduce unnecessary colonoscopies and detect recurrence earlier when inflammation is...
Fecal calprotectin from ileostomy output in patients with Crohn's disease | BMC Gastroenterology
People with Crohn’s disease who have an ileostomy have limited noninvasive ways to monitor small-bowel inflammation. This study suggests measuring fecal calprotectin from ileostomy output could help detect postoperative...